CANCER GENETICS, INC Stock Agreements
13 Contracts & Agreements
- Form of Stock Unit Award Agreement (Filed With SEC on April 5, 2021)
- Form of Nonqualified Stock Option Grant Agreement (Filed With SEC on April 5, 2021)
- COMMON STOCK PURCHASE AGREEMENT (Filed With SEC on August 16, 2017)
- STOCK PURCHASE AGREEMENT among VIVOPHARM PTY. LTD. BRANDT FAMILY TRUST SOUTH AUSTRALIAN LIFE SCIENCE ADVANCEMENT PARTNERSHIP, LP ROYAL MELBOURNE INSTITUTE OF TECHNOLOGY MANAGEMENT... (Filed With SEC on August 16, 2017)
- CANCER GENETICS, INC. Shares of Common Stock (par value $0.0001 per share) Controlled Equity OfferingSM Sales Agreement (Filed With SEC on July 16, 2015)
- STOCK PURCHASE AGREEMENT (Filed With SEC on August 18, 2014)
- CANCER GENETICS, INC. AMENDED AND RESTATED 2008 STOCK OPTION PLAN (Filed With SEC on October 23, 2012)
- FORM OF EXERCISE NOTICE AND RESTRICTED STOCK PURCHASE AGREEMENT (Filed With SEC on December 30, 2011)
- FORM OF STOCK OPTION AGREEMENT (Filed With SEC on December 30, 2011)
- FORM OF NOTICE OF STOCK OPTION GRANT (Filed With SEC on December 30, 2011)
- 2008 STOCK OPTION PLAN (Filed With SEC on December 30, 2011)
- AMENDMENT AND WAIVER TO SERIES B CONVERTIBLE PREFERRED STOCK PURCHASE AGREEMENT (Filed With SEC on December 30, 2011)
- SERIES B CONVERTIBLE PREFERRED STOCK PURCHASE AGREEMENT (Filed With SEC on December 30, 2011)
